Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
Date:9/9/2008

12,012,000 7,440,000

Capital lease obligation, less current

portion 16,000 22,000

Commitments and contingencies

STOCKHOLDERS' EQUITY:

Preferred stock -- $.001 par value;

authorized 5,000,000 shares; non-voting;

nil shares outstanding - -

Common stock -- $.001 par value;

authorized 325,000,000 shares;

outstanding -- 226,210,617 and 226,210,617,

respectively 226,000 226,000

Additional paid-in capital 246,476,000 246,205,000

Accumulated deficit (235,922,000) (230,836,000)

Total stockholders' equity 10,780,000 15,595,000

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $22,808,000 $23,057,000

PEREGRINE PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

THREE MONTHS ENDED

July 31, 2008 July 31, 2007

Unaudited Unaudited

REVENUES:

Contract manufacturing revenue $1,193,000 $1,621,000

Government contract revenue 324,000 -

License revenue - 4,000

Total revenues 1,517,000 1,625,000

COSTS AND EXPENSES:

Cost of contract manufacturing 903,000 1,181,000

Research and development 4,068,000 3,624,000

Selling, general and administrative 1,706,000 1,708,000

Total costs and expenses 6,677,000 6,513,000

LOSS FROM OPERATIONS (5,160,000) (4,888,000)

OTHE
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
2. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
3. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
4. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
5. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
6. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
7. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
8. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
9. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
10. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 Synthetic Biologics, Inc. ... prevention and treatment of serious infectious diseases, announced today that ... th Annual OneMedForum New York Conference on Thursday, June ... York City . Mr. Riley is scheduled to present ... of Synthetic Biologics, presentation can be accessed by logging onto ...
(Date:6/19/2013)...   NineSigma , Inc., of Cleveland ... launch, NineSights.com is now the innovation engine ... worldwide community of innovators. From technology developers, ... NineSights stands out for its large community of innovators ... disciplines, all vetted by NineSigma. The community is free ...
(Date:6/19/2013)... ANGELES , June 19, 2013 Biotechnology industry ... teaming up with financial software provider BlackLine Systems ... SAP ) for a webinar next week entitled ... Uses Solutions from BlackLine and SAP to Help Keep Its ... (Logo: http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 India’s ... business can potentially be worth up to a ... opportunity, the Indian government is taking serious action ... the process. , This presentation will examine:, ... regulations ,     Immediate and long term impacts ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4
... companies tied for the top prize at the first-annual ... close of the Entrepreneurs Conference Wednesday evening in Milwaukee, ... first and second place, or $55,000. , ,Other category ... IntelliMentor. , ,The quality of the business plans was ...
... MILWAUKEE The Wisconsin Entrepreneurs Conference ... flourish in a competitive market, with a seminar ... market potential of ideas. Entrepreneurs and industry representatives ... shared strategies for making a product survive and ...
... MADISON Be honest: Everything you know about nanotechnology is ... meets the super-model, and within the space of about 30 ... nerdy baby wearing eyeglasses. , ,Dont feel left out, however, ... backyard grill. The field of nanotechnology is so new that ...
Cached Biology Technology:Governors business-plan contest has a surprise ending 2Governors business-plan contest has a surprise ending 3Governors business-plan contest has a surprise ending 4Governors business-plan contest has a surprise ending 5Governors business-plan contest has a surprise ending 6Entrepreneurs learn to assess potential ideas 2Entrepreneurs learn to assess potential ideas 3Small wonders: Intersection of biotech and nanotech will produce big advances 2Small wonders: Intersection of biotech and nanotech will produce big advances 3
(Date:6/19/2013)... 19, 2013 Elsevier, a world-leading provider of scientific, ... to announce the launch of a new open access ... of GeoResJ , Elsevier,s earth and planetary science ... The journal aims to provide a forum for rapid ... field. The journal will be co-edited by six Executive ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
(Date:6/18/2013)... National Institutes of Health has awarded $12.7 million ... selection of pharmaceutical industry compounds to explore new ... Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. The ... for Existing Molecules, is led by the National ... by the NIH Common Fund. , The process ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... and their colleagues at other research centers have found a ... the impact of the aging process. Their study, which will ... lends more credence to the free-radical theory of aging. , ... can be damaging to the body at the cellular level. ...
... Results showed that the microbes in about a half a ... the rumen, the largest chamber of a cow's stomach - ... voltage needed to run one rechargeable AA-sized battery, said Ann ... agricultural and biological engineering at Ohio State University. , While ...
... brain develops, neurons reach out helter-skelter forming new connections, ... the brain chooses which connections to keep and which ... branches have the most electrical activity—a finding that could ... , The work, published in the April 21 issue ...
Cached Biology News:Researchers extend mouse lifespan by protecting against free radicals 2Researchers extend mouse lifespan by protecting against free radicals 3It's electric: Cows show promise as powerplants 2It's electric: Cows show promise as powerplants 3Speak up: Louder neurons form more connections 2
... 23 years of experience in the development ... antibodies to large and small peptides, proteins, ... plasmid DNA-encoded antigens. We understand and appreciate ... hybridoma development programs are never "cookbook". We ...
... Solubility Service, We deliversoluble protein or ... technology yields the best soluble protein results ... each clone submitted , Powerful results on ... protein Solubility Optimization Service (SOS) uses proprietary ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... Formula variant: With the macro- ... Murashige and Skoog (1962) and ... Gamborg, et al. (1968). Preparation ... 4.4 grams of powder per ...
Biology Products: